Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
The wealth management industry has warned of a looming advisor succession crisis. But changing retirement patterns, AI-driven scale, and a broader talent pool may be rewriting the equation.
Faculty
IPOs reflect market momentum and investors’ risk perception, writes ERM lecturer Saba Zahid.
Alumni, Faculty
Jo Jose (’25SPS), a faculty associate and alum, shares how the M.S. in Technology Management program connects students with industry leaders, collaborative projects, and practical marketing experience.
All News
